HEAD AND NECK CANCER: HOW A SIMPLE BLOOD TEST CAN DETECT CANCER, UP TO 10 YEARS AHEAD

In what may be a landmark moment in cancer detection, researchers have unveiled a simple blood test capable of catching head and neck cancers up to ten years before symptoms show. This test, particularly aimed at cancers linked to the human papillomavirus (HPV), uses advanced genomic tools and machine learning to spot tiny fragments of tumor DNA circulating silently in the blood.

This breakthrough offers hope for early intervention, less aggressive treatments, and vastly improved outcomes. If validated and scaled up, it could transform how we screen, treat, and manage these cancers – shifting from late-stage, harmful interventions to early, less invasive care.

A recent study by the Harvard-affiliated Mass General Brigham system has introduced a groundbreaking blood test, called HPV-DeepSeek, which can detect HPV-associated head and neck cancers years before symptoms emerge. Unlike conventional methods that wait for a tumor to cause visible signs, this test works by scanning for DNA fragments shed by tumors into the bloodstream long before the disease becomes visible.

HPV is responsible for roughly 70% of oropharyngeal (throat) cancers in certain populations, making it a major health concern. Yet until now, there has been no reliable screening test for these cancers – unlike cervical cancer, where PAP smears and HPV tests are routine.

Because these cancers often produce few or no early symptoms, many are discovered late, after they have grown large or spread to lymph nodes. Detecting cancer long before signs appear could reduce the need for extensive surgeries, radiation, and chemotherapy, thereby lowering treatment side effects and improving survival.

Full article:

https://news.harvard.edu/gazette/story/2025/09/new-blood-test-detects-cancer-10-years-early/